Skip to content

Funding Announcements

Filter

Filter & sort

Keyword

Tag

Round

Sort by

Clear

The latest funding rounds from the UK tech ecosystem. Updated 16 October 2026.

Announcements

503

Total raised

£3.8B

disclosed amounts

This month

£36.9M

raised so far

Other
€4.0M

The funding round was backed by Guinness Ventures, Conduit Fund, Octopus Ventures, and Macmillan Cancer Support, exceeding the company's initial €2m target.

"Supporting businesses developing scalable, meaningful impact in healthcare is a priority for us,"
— Eva-Maria Dimitriadis, Managing Partner
£880K

The funding round includes £375k from the British Business Bank via The FSE Group.

"HCI’s client base already includes over 20 NHS organisations, multi-national insurance companies, and hospitals in European territories. With an experienced team well-versed in NHS program delivery and a robust and adaptable solution for complex healthcare challenges, HCI is well-positioned to lead the charge in transforming healthcare delivery. We are thrilled to support the team in their journey to innovate patient care."
— Ralph Singleton, Head of Equity South West
Seed
£250K

The funding combines angel capital and an Innovate UK grant to support product development and sales expansion.

"We’re solving a workflow problem that affects the entire care ecosystem. Care teams are spending hours on manual documentation and communication tasks. Our platform automates these processes whilst creating the transparency that families want."
— Zeezy Izenman, CEO and founder
Seed
£150K

British Design Fund backs the medical technology startup as it prepares to launch its first consumer products.

"We are delighted to have the backing of the British Design Fund. Sleep health has a profound impact on physical and mental wellbeing, and our technology is designed to help individuals and families achieve better rest. With the support of our investors, we are one step closer to making refreshing, uninterrupted sleep a reality for everyone."
— Nigel Clarke, CEO
£425K

EHE Ventures led the round with support from Deepbridge Capital and Lyva Labs to accelerate product development and regulatory approval.

"Spotlight Pathology represents exactly the type of highly innovative company that Deepbridge is privileged to invest in. We initially supported the team through our Seed Enterprise Investment Scheme (SEIS), and are now pleased to back them again through our EIS fund, alongside EHE and Lyva Labs. We look forward to supporting the team as they scale in the exciting field of digital pathology."
— Andrew Round, Investment Director